Auxly Closes Transformational Debt Reduction Transactions, Strengthens Financial Position and Unlocks Growth Potential

TORONTO, July 8, 2025 /PRNewswire/ – Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, is pleased to announce the successful closing of two transformative financial transactions previously announced on June 19, 2025: the amendment and extension of its credit facility […]

LakeShore Biopharma Announces US$15 Million Private Placement Financing

BEIJING, July 8, 2025 /PRNewswire/ — LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has entered into a share and warrant purchase agreement (the “Purchase Agreement”) with an […]

BTQ Launches World’s First Quantum Proof-of-Work Simulator, Delivering the First Commercial Demonstration of Quantum Advantage in Blockchain Consensus

BTQ Quantum Proof-of-Work (QPoW) Simulator offers a live, interactive platform to demonstrate quantum-native consensus mechanisms that remain compatible with existing blockchain infrastructure. QPoW delivers measurable quantum advantage while eliminating vulnerabilities to quantum attacks, offering energy-efficient, post-quantum secure alternatives to legacy proof-of-work systems. The release follows BTQ’s leadership role in global standards development, with QPoW adopted […]

Soligenix Corporate Update Letter – Key Highlights and Upcoming Milestones

PRINCETON, N.J., July 8, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber. The content of […]

Clarivate to Report Second Quarter 2025 Results on July 30, 2025

LONDON, July 8, 2025 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate […]

Clarivate to Report Second Quarter 2025 Results on July 30, 2025

LONDON, July 8, 2025 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate […]

Curaleaf Holdings Announces Buyout of Minority Partner in Curaleaf International

STAMFORD, Conn., July 8, 2025 /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA, OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced that it has acquired the equity stake in Curaleaf International Holdings Limited (“Curaleaf International”) previously held by a single strategic institutional investor. The transaction brings the Company’s stake […]

Cochlear Launches World’s First and Only Smart Cochlear Implant System

Upgradeable Firmware: The Cochlear™ Nucleus® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates. Smallest Sound Processor: The new Nucleus 8 Nexa Sound Processor, with the new Power Compact rechargeable battery, is the smallest sound processor with all day battery life# on the market. […]